Effective Vaccine Against Dengue on the Cards

Saturday, July 04, 2015

Dengue Vaccine

Researchers from Vanderbilt University and National University of Singapore have determined the structure of human monoclonal antibody that can neutralise the deadly dengue virus. In lab tests conducted on a mouse model the antibody prevented dengue virus from fusing with its target cell thus preventing infection.

The development could lead to an effective vaccine against dengue virus that infects around 390 million people annually and is a major reason for high deaths in the tropics. For the study, scientists used cryo-electron microscopy to freeze samples at very low temperatures so they could visualise antibody-antigen binding to the atomic level. By doing so, they were able to identify human monoclonal antibody against dengue virus type 2 (DENV2) that locked across an array of envelope proteins.

Dengue is a complex of four distinct but related mosquito-borne viruses. These four distinct viruses are classified as serotypes which contain different antigens, or proteins on the viral envelope that elicit immune responses. A major challenge in treating dengue is that vaccines target only one serotype at a time which gives a leeway to other three serotypes to enhance infection. The study was published in the journal Science. 

The most wonderful and precious element of universe is the human life which can only be guided by the right knowledge and right attitude. So, here is an ocean of knowledge, both in English and Hindi encompassing every detail and each facet of human life which ‘one must know’ in order to grow and attain the summits of success. A team of around 200 dedicated members is working ceaselessly to turn such a colossal dream into reality. We are confident that this portal will help bring change in people across the world.

Content creation, research, development and execution done in-house at Aatman Innovations.